Pfizer seeking emergency use of COVID-19 vaccine
Pfizer Inc. announced Friday that they seeking approval of U.S. regulators to allow the use of it’s COVID-19 vaccine.
Before any vaccine is approved for the public the U.S. Food and Drug Administration must conduct a full review of the vaccine trials, a process that normally takes about a decade.
The pandemic has caused the federal government to use various methods to speed up the process for COVID-19 vaccines.
On Wednesday, Pfizer released it’s preliminary data showing the vaccine is 95% effective.
The company said the data and good safety measures should help the vaccine qualify for emergency use authorization.
Watch the video for the full story.
Virtual holiday parties helping stop the spread of COVID-19
Weslaco family spreading holiday cheer by turning their home into Northopolis
McAllen named one of the safest border cities in the country
Hidalgo County health officials keeping a close eye on available hospital beds...
A San Benito family mourning the loss of 4 family members involved...